Though elevated serum levels of IGFBP2 have been demonstrated in a number of cancers, including ovarian [10], this is the first evidence that IGFBP1 levels increase in serum or plasma of patients with ovarian cancer. Here, IGFBP2 is linked to ovarian cancer.